Obesity Research
Clinical Trial

Obesity Research Clinical Trial in Denver

Clinical trials are avaible to eligible patients at GI of the Rockies. This trial is designed for people with obesity and diabetes, however, our obesity research clinical trial is currently full and we are not accepting participants at this time.

For future enrollment, please check back if you are curious about this clinical trial.

We will continue offering various clinical trials in Denver with our trusted partner, Advanced Research Institute (ARI).

ARI staff are available to answer your questions about this obesity research trial and help determine if you qualify for the study. Qualified participants may potentially gain access to GLP-1/GIP dual agonist medications.

About the Obesity Clinical Trial

In previous research studies, GLP-1 receptor agonists have shown significant weightloss outcomes, reported in 2024, in the journal Obesity.

The question is: Could this type of therapy potentially work for you?

Want More Information About Obesity Research Clinical Trials in Denver?

If you’ve tried different weight loss methods or medications and felt unsatisfied with the results – we encourage you to request more information about this obesity research study. Many people report a lack of satiety when trying to shed pounds. Learn how GLP-1/GIP dual agonist therapies may help some people with satiety levels and weight loss.

Find out how GLP-1/GIP dual agonist medications work with major organs — like the brain, pancreas and stomach. Curious about how or why dual agonist medications may have potential to help some people who are overweight and obese? So are we. That’s why we are excited about launching this obesity research clinical trial.

According to growing body of evidence-based research, some overweight people may respond better to therapies with both GLP 1 and GIP components – as these combined peptides target appetite hormones and other metabolic factors. See the graphic illustration.

Sources: JAMA Internal Medicine, 2024 & Washington University, St. Louis, 2025

Curious about the pancreas? Check out our page that explores this important organ and how it helps the liver, small intestine and gallbladder.

________________________________________________________________________

Check back with us

Please check back to learn about future clinical trials in Denver?

Graphic display of GLP1 medication and its effect on major organs, like brain, pancreas, stomach — Glucagon-like peptide-1. GLP-1 from blood vessel to pancreas, brain and stomach looks at the relationship between satiety, appetite hormones, insulin, glucagon, gastric motility, and emptying.